At all three experimental time points, under the microscope, normal human ADSC from three donors challenged with recombinant human TGFβ1 and serum from patients with SSc showed decreased red-colored lipid droplets compared to both basal and healthy serum-treated ADSC (Figure 1A). The gene discussed is TGFB1; the disease is systemic sclerosis.